Histological grading of ovarian clear cell adenocarcinoma: Proposal for a simple and reproducible grouping system based on tumor growth architecture

International Journal of Gynecological Pathology

Volumn 31, Issue 2, 2012, Pages 116-124

  Yamamoto, Sohei ^a   Tsuda, Hitoshi ^a,h   Shimazaki, Hideyuki ^a   Takano, Masashi ^a   Yoshikawa, Tomoyuki ^a   Kuzuya, Kazuo ^c,i   Tsuda, Hiroshi ^d,j   Kurachi, Hirohisa ^e   Kigawa, Junzo ^f   Kikuchi, Yoshihiro ^b   Sugiyama, Toru ^g   Matsubara, Osamu ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b Ohki Memorial Kikuchi Cancer Clinic for Women   (Japan)

^c AICHI CANCER CENTER HOSPITAL   (Japan)

^d OSAKA CITY GENERAL HOSPITAL   (Japan)

^e YAMAGATA UNIVERSITY   (Japan)

^f TOTTORI UNIVERSITY HOSPITAL   (Japan)

^g IWATE MEDICAL UNIVERSITY   (Japan)

^h NATIONAL CANCER CENTER HOSPITAL   (Japan)

ⁱ Kuzuya Clinic   (Japan)

^j KEIO UNIVERSITY   (Japan)

more..

Author keywords

Clear cell adenocarcinoma; Histological grade; Histology; Ovarian cancer; Tumor differentiation

Indexed keywords

ADULT; ARTICLE; CANCER GRADING; CANCER SURVIVAL; CELL DIFFERENTIATION; CELL INFILTRATION; CONTROLLED STUDY; FEMALE; HISTOLOGY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; OVARY ADENOCARCINOMA; PRIORITY JOURNAL; TUMOR CELL; TUMOR CLASSIFICATION; TUMOR GROWTH;

ADENOCARCINOMA, CLEAR CELL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; NEOPLASM GRADING; NEOPLASM STAGING; OVARIAN NEOPLASMS; REPRODUCIBILITY OF RESULTS;

EID: 84863415105     PISSN: 02771691     EISSN: 15387151     Source Type: Journal    
DOI: 10.1097/PGP.0b013e3182285c90     Document Type: Article

References (20)

1. Seidman JD, Russell P, Kurman RJ. Surface epithelial tumors of the ovary. In: Kurman RJ, ed. Blaustein's Pathology of the Female Genital Tract. 5th ed. New York, Springer-Verlag; 2001:791-904.
2. Sugiyama T, Kamura T, Kigawa J, et al. Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy. Cancer 2000;88:2584-9. (Pubitemid 30331967)
3. Ikeda K, Sakai K, Yamamoto R, et al. Multivariate analysis for prognostic significance of histologic subtype, GST-pi, MDR-1, and p53 in stages II-IV ovarian cancer. Int J Gynecol Cancer 2003;13:776-84. (Pubitemid 38235222)
4. Lee KR, Tavassoli FA, Part J, et al. Surface epithelial-stromal tumours. In: Tavassoli FA, Devilee P, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyon: IARC Press 2003.
5. Kaku T, Ogawa S, Kawano Y, et al. Histological classification of ovarian cancer. Med Electron Microsc 2003;36:9-17. (Pubitemid 36504385)
6. Gynecologic cancer comittee, Japan society of obstetrics and gynecology. Annual report of gynecological cancer patients in Japan 2006. Acta Obstetrica et Gynecologica Japonica. 2008; 60; 1001-1085 (In Japanese).
7. Crozier MA, Copeland LJ, Silva EG, et al. Clear cell carcinoma of the ovary: a study of 59 cases. Gynecol Oncol 1989;35:199-203. (Pubitemid 19268557)
8. Kennedy AW, Biscotti CV, Hart WR, et al. Histologic correlates of progression-free interval and survival in ovarian clear cell adenocarcinoma. Gynecol Oncol 1993;50:334-8. (Pubitemid 23299729)
9. Omura GA, Brady MF, Homesley HD, et al. Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience. J Clin Oncol 1991;9:1138-50.
10. Chan JK, Teoh D, Hu JM, et al. Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers. Gynecol Oncol 2008;109:370-6.
11. Mizuno M, Kikkawa F, Shibata K, et al. Long-term follow-up and prognostic factor analysis in clear cell adenocarcinoma of the ovary. J Surg Oncol 2006;94:138-43. (Pubitemid 44267195)
12. O'Brien ME, Schofield JB, Tan S, et al. Clear cell epithelial ovarian cancer (mesonephroid): bad prognosis only in early stages. Gynecol Oncol 1993;49:250-4. (Pubitemid 23170001)
13. Takano M, Kikuchi Y, Yaegashi N, et al. Clear cell carcinoma of the ovary: a retrospective multicentre experience of 254 patients with complete surgical staging. Br J Cancer 2006;94: 1369-74. (Pubitemid 43772268)
14. International Federation of Gynecology and Obstetrics. Classification and staging of malignant tumours in the female pelvis. Acta Obstet Gynecol Scand 1971;50:1-7.
15. Shimizu Y, Kamoi S, Amada S, et al. Toward the development of a universal grading system for ovarian epithelial carcinoma: testing of a proposed system in a series of 461 patients with uniform treatment and follow-up. Cancer 1998; 82:893-901. (Pubitemid 28104169)
16. Yamamoto S, Tsuda H, Shimazaki H, et al. Clear cell adenocarcinoma with a component of poorly differentiated histology: a poor prognostic subgroup of ovarian clear cell adenocarcinoma. Int J Gynecol Pathol 2010 (In press).
17. Montag AG, Jenison EL, Griffiths CT, et al. Ovarian clear cell carcinoma. A clinicopathologic analysis of 44 cases. Int J Gynecol Pathol 1989;8:85-96. (Pubitemid 19116244)
18. Imachi M, Tsukamoto N, Shimamoto T, et al. Clear cell carcinoma of the ovary: a clinicopathologic analysis of 34 cases. Int J Gynecol Cancer 1991;1:113-9.
19. Yamamoto S, Kasajima A, Takano M, et al. Validation of the histological grading for ovarian clear-cell adenocarcinoma: a retrospective multi-institutional study by the Japan Clear Cell Carcinoma Study Group. Int J Gynecol Pathol 2011;30: 129-38.
20. Collan Y, Torkkeli T, Kosma VM, et al. Sampling in diagnostic morphometry: the influence of variation sources. Pathol Res Pract 1987;182:401-6. (Pubitemid 17111046)